Pleiotropic effects of growth hormone signaling in aging

Trends in Endocrinology and Metabolism

Volumn 22, Issue 11, 2011, Pages 437-442

  Bartke, Andrzej ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN;

AGING; CALORIC RESTRICTION; FITNESS; HUMAN; LONGEVITY; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; REPRODUCTION; REVIEW;

AGING; ANIMALS; GENETIC PLEIOTROPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MICE; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 82455164216     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.07.004     Document Type: Review

References (68)

1. Brown-Borg H.M., et al. Dwarf mice and the aging process. Nature 1996, 384:33.
2. Coschigano K.T., et al. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 2000, 141:2608-2613.
3. Flurkey K., et al. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6736-6741.
4. Bartke A. Growth hormone and aging: a challenging controversy. Clin. Interv. Aging 2008, 3:659-665.
5. Russell S.J., Kahn C.R. Endocrine regulation of ageing. Nat. Rev. Mol. Cell Biol. 2007, 8:681-691.
6. Miller R.A. Kleemeier Award Lecture: are there genes for aging?. J. Gerontol. A: Biol. Med. Sci. 1999, 54A:B297-B307.
7. Samaras T.T. Human Body Size and The Laws of Scaling: Physiological, Performance, Growth, Longevity and Ecological Ramifications 2007, Nova Science Publishers.
8. Conover C.A., Bale L.K. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 2007, 6:727-729.
9. Taguchi A., et al. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 2007, 317:369-372.
10. Selman C., et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009, 326:140-144.
11. Harrison D.E., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
12. Lupu F., et al. Roles of growth hormone and insulin-like growth factor I in mouse postnatal growth. Dev. Biol. 2001, 229:141-162.
13. Bartke A., et al. Growth hormone, IGF-1, insulin and long-lived mutant mice. Longevity, Mitochondria and Oxygen Free Radicals 2010, 137-156. Research Signpost, Kerala, India. R. Pamplona, G. Barja (Eds.).
14. Yuan R., et al. Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 2009, 8:277-287.
15. Miller R.A., et al. Big mice die young: early life body weight predicts longevity in genetically heterogeneous mice. Aging Cell 2002, 1:22-29.
16. Eigenmann J.E., et al. Insulin-like growth factor I levels in proportionate dogs, chondrodystrophic dogs and in giant dogs. Acta Endocrinol. (Copenh) 1988, 118:105-108.
17. Stuart J.A., Page M.M. Plasma IGF-1 is negatively correlated with body mass in a comparison of 36 mammalian species. Mech. Ageing Dev. 2010, 131:591-598.
18. Bonkowski M.S., et al. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7901-7905.
19. Masternak M.M., et al. Insulin sensitivity as a key mediator of growth hormone actions on longevity. J. Gerontol. A: Biol. Sci. Med. Sci. 2009, 64:516-521.
20. Bonkowski M.S., et al. Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity. PLoS ONE 2009, 4:e4567.
21. Dominici F.P., et al. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm. IGF Res. 2005, 15:324-336.
22. Adochio R., et al. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of AKT-mTor-S6K1 pathway and serine phosphorylation of IRS-1: effect of reduced p85a subunit of phosphatidylinositol 3 kinase and S6K1 kinase. Endocrinology 2008, 150:1165-1173.
23. Al-Regaiey K.A., et al. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor 1/insulin signaling and caloric restriction. Endocrinology 2005, 146:851-860.
24. Zhou Y., et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13215-13220.
25. Westbrook R., et al. Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice. J. Gerontol. A: Biol. Sci. Med. Sci. 2009, 64A:443-451.
26. Salmon A.B., et al. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E23-E29.
27. Miller R.A. Cell stress and aging: new emphasis on multiplex resistance mechanisms. J. Gerontol. A: Biol. Sci. Med. Sci. 2009, 64:179-182.
28. Bokov A.F., et al. Long-lived Ames dwarf mice are resistant to chemical stressors. J. Gerontol. A: Biol. Sci. Med. Sci. 2009, 64:819-827.
29. Amador-Noguez D., et al. Gene expression profile of long-lived Ames dwarf mice and Little mice. Aging Cell 2004, 3:423-441.
30. Amador-Noguez D., et al. Gender-specific alterations in gene expression and loss of liver sexual dimorphism in the long-lived Ames dwarf mice. Biochem. Biophys. Res. Comm. 2005, 332:1086-1100.
31. Panici J.A., et al. Is altered expression of hepatic insulin-related genes in growth hormone receptor knockout mice due to GH resistance or a difference in biological life spans?. J. Gerontol. A: Biol. Sci. Med. Sci. 2009, 64:1126-1133.
32. Kinney B.A., et al. Evidence that Ames dwarf mice age differently from their normal siblings in behavioral and learning and memory parameters. Horm. Behav. 2001, 39:277-284.
33. Kinney B.A., et al. Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice. Physiol. Behav. 2001, 72:653-660.
34. Kinney-Forshee B., et al. Could a deficiency in growth hormone signaling be beneficial to the aging brain?. Physiol. Behav. 2004, 80:589-594.
35. Sun L.Y., et al. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol. Aging 2005, 26:929-937.
36. Sun L.Y., Bartke A. Adult neurogenesis in the hippocampus of long-lived mice during aging. J. Gerontol. A: Biol. Sci. Med. Sci. 2007, 62:117-125.
37. Schrag M., et al. Hippocampus of Ames dwarf mice is resistant to beta-amyloid-induced tau hyperphosphorylation and changes in apoptosis-regulatory protein levels. Hippocampus 2008, 18:239-244.
38. Sharma S., et al. The hippocampus of Ames dwarf mice exhibits enhanced antioxidative defenses following kainic acid-induced oxidative stress. Exp. Gerontol. 2010, 45:936-949.
39. Sun L.Y., et al. Fibroblasts from long-lived mutant mice show diminished ERK1/2 phosphorylation but exaggerated induction of immediate early genes. Free Radic. Biol. Med. 2009, 47:1753-1761.
40. Banks W.A., et al. Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:22272-22277.
41. Swindell W.R., et al. Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice. Mech. Ageing Dev. 2009, 130:393-400.
42. Leiser S.F., Miller R.A. Nrf2 signaling, a mechanism for cellular stress resistance in long-lived mice. Mol. Cell. Biol. 2010, 30:871-884.
43. Sun L.Y., et al. Hepatic response to oxidative injury: qualitative differences in long-lived Ames dwarf mice. FASEB J. 2011, 25:398-408.
44. Brown-Borg H., et al. Mitochondrial oxidant generation and oxidative damage in Ames dwarf and GH transgenic mice. J. Am. Aging Assoc. 2001, 24:85-96.
45. Brown-Borg H.M., et al. Growth hormone alters methionine and glutathione metabolism in Ames dwarf mice. Mech. Ageing Dev. 2005, 126:389-398.
46. Garcia A.M., et al. Effect of Ames dwarfism and caloric restriction on spontaneous DNA mutation frequency in different mouse tissues. Mech. Ageing Dev. 2008, 129:528-533.
47. Bates D.J., et al. MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging. Aging Cell 2010, 9:1-18.
48. Helms S.A., et al. Smaller cardiac cell size and reduced extra-cellular collagen might be beneficial for hearts of Ames dwarf mice. Int. J. Biol. Sci. 2010, 6:475-490.
49. Ratajczak J., et al. Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice-novel view on Igf-1, stem cells and aging. Leukemia 2011, 25:729-733.
50. Wang Z., et al. Adipocytokines and lipid levels in Ames dwarf and caloric restricted mice. J. Gerontol. A: Biol. Sci. Med. Sci. 2006, 61A:323-331.
51. Sonntag W.E., et al. Moderate caloric restriction alters the subcellular distribution of somatostatin mRNA and increases growth hormone pulse amplitude in aged animals. Neuroendocrinology 1995, 61:601-608.
52. Fontana L., et al. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell 2008, 7:681-687.
53. Bartke A., et al. Longevity: extending the lifespan of long-lived mice. Nature 2001, 414:412.
54. Cohen D.E., et al. Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction. Genes Dev. 2009, 23:2812-2817.
55. Dani S.U., et al. Survival of the thriftiest: restricted nurture reveals the thrifty nature of a growth gene in Bos indicus. Genet. Mol. Res. 2010, 9:1032-1044.
56. Mullis P.E., et al. Isolated autosomal dominant growth hormone deficiency (IGHD II). An evolving pituitary deficit? A multi-center follow-up study. J. Clin. Endocrinol. Metab. 2005, 10:1210.
57. Krzisnik C., et al. The 'Little People' of the island of Krk - revisited. Etiology of hypopituitarism revealed. J. Endocr. Genet. 1999, 1:9-19.
58. Laron Z. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity?. Mech. Ageing Devel. 2005, 126:305-307.
59. Oliveira C.R., et al. Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 2010, 95:693-698.
60. Aguiar-Oliveira M.H., et al. Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 2010, 95:714-721.
61. Shevah O., Laron Z. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm. IGF Res. 2007, 17:54-57.
62. Shechter M., et al. Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function. Growth Horm. IGF Res. 2007, 17:165-170.
63. Guevara-Aguirre J., et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 2011, 3:70ra13.
64. Mavalli M.D., et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J. Clin. Invest. 2010, 120:4007-4020.
65. Bartke A., et al. Does growth hormone prevent or accelerate aging?. Exp. Gerontol. 1998, 33:675-687.
66. Rosa C.E., et al. GH overexpression modifies muscle expression of anti-oxidant enzymes and increases spinal curvature of old zebrafish. Exp. Gerontol. 2010, 45:449-456.
67. Jadresic A., et al. The acromegaly syndrome. Q. J. Med. 1982, 202:189-204.
68. Orme S.M., et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J. Clin. Endocrinol. Metabol. 1998, 83:2730-2734.